skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 218,374  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Refined by: Database: Open Access: PubMed Central remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cells
Material Type:
Article
Add to My Research

miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cells

PloS one, 2013-03, Vol.8 (3), p.e60317-e60317 [Peer Reviewed Journal]

COPYRIGHT 2013 Public Library of Science ;2013 Chen et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2013 Chen et al 2013 Chen et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0060317 ;PMID: 23555954

Full text available

2
RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer
Material Type:
Article
Add to My Research

RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer

Nature communications, 2015-03, Vol.6 (1), p.6377-6377, Article 6377 [Peer Reviewed Journal]

Copyright Nature Publishing Group Mar 2015 ;Copyright © 2015, Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/ncomms7377 ;PMID: 25758528

Full text available

3
Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8 + T cell exhaustion
Material Type:
Article
Add to My Research

Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8 + T cell exhaustion

Nature communications, 2020-09, Vol.11 (1), p.4520-4520, Article 4520 [Peer Reviewed Journal]

The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-020-18298-8 ;PMID: 32908154

Full text available

4
Over-expression of LSD1 promotes proliferation, migration and invasion in non-small cell lung cancer
Material Type:
Article
Add to My Research

Over-expression of LSD1 promotes proliferation, migration and invasion in non-small cell lung cancer

PloS one, 2012-04, Vol.7 (4), p.e35065-e35065 [Peer Reviewed Journal]

COPYRIGHT 2012 Public Library of Science ;COPYRIGHT 2012 Public Library of Science ;2012 Lv et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Lv et al. 2012 ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0035065 ;PMID: 22493729

Full text available

5
Progress and prospects of early detection in lung cancer
Material Type:
Article
Add to My Research

Progress and prospects of early detection in lung cancer

Open biology, 2017-09, Vol.7 (9), p.170070 [Peer Reviewed Journal]

2017 The Authors. ;2017 The Authors. 2017 ;ISSN: 2046-2441 ;EISSN: 2046-2441 ;DOI: 10.1098/rsob.170070 ;PMID: 28878044

Full text available

6
Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers
Material Type:
Article
Add to My Research

Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers

PloS one, 2015-06, Vol.10 (6), p.e0130142-e0130142 [Peer Reviewed Journal]

COPYRIGHT 2015 Public Library of Science ;COPYRIGHT 2015 Public Library of Science ;2015 Carbognin et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2015 Carbognin et al 2015 Carbognin et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0130142 ;PMID: 26086854

Full text available

7
Crizotinib-induced immunogenic cell death in non-small cell lung cancer
Material Type:
Article
Add to My Research

Crizotinib-induced immunogenic cell death in non-small cell lung cancer

Nature communications, 2019-04, Vol.10 (1), p.1486-17, Article 1486 [Peer Reviewed Journal]

This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Distributed under a Creative Commons Attribution 4.0 International License ;The Author(s) 2019 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-019-09415-3 ;PMID: 30940805

Full text available

8
Diversity and heterogeneity of immune states in non-small cell lung cancer and small cell lung cancer
Material Type:
Article
Add to My Research

Diversity and heterogeneity of immune states in non-small cell lung cancer and small cell lung cancer

PloS one, 2021-12, Vol.16 (12), p.e0260988-e0260988 [Peer Reviewed Journal]

COPYRIGHT 2021 Public Library of Science ;2021 Rice, Belani. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Rice, Belani 2021 Rice, Belani ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0260988 ;PMID: 34855926

Full text available

9
PARP inhibition enhances tumor cell-intrinsic immunity in ERCC1-deficient non-small cell lung cancer
Material Type:
Article
Add to My Research

PARP inhibition enhances tumor cell-intrinsic immunity in ERCC1-deficient non-small cell lung cancer

The Journal of clinical investigation, 2019-03, Vol.129 (3), p.1211-1228 [Peer Reviewed Journal]

COPYRIGHT 2019 American Society for Clinical Investigation ;COPYRIGHT 2019 American Society for Clinical Investigation ;Copyright American Society for Clinical Investigation Mar 2019 ;Copyright © 2019, American Society for Clinical Investigation 2019 American Society for Clinical Investigation ;ISSN: 0021-9738 ;EISSN: 1558-8238 ;DOI: 10.1172/jci123319 ;PMID: 30589644

Full text available

10
Alteration in tumoural PD-L1 expression and stromal CD8-positive tumour-infiltrating lymphocytes after concurrent chemo-radiotherapy for non-small cell lung cancer
Material Type:
Article
Add to My Research

Alteration in tumoural PD-L1 expression and stromal CD8-positive tumour-infiltrating lymphocytes after concurrent chemo-radiotherapy for non-small cell lung cancer

British journal of cancer, 2019-09, Vol.121 (6), p.490-496 [Peer Reviewed Journal]

Copyright Nature Publishing Group Sep 2019 ;The Author(s), under exclusive licence to Cancer Research UK 2019 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-019-0541-3 ;PMID: 31388183

Full text available

11
Metformin use and lung cancer survival: a population-based study in Norway
Material Type:
Article
Add to My Research

Metformin use and lung cancer survival: a population-based study in Norway

British journal of cancer, 2021-03, Vol.124 (5), p.1018-1025 [Peer Reviewed Journal]

The Author(s), under exclusive licence to Cancer Research UK 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s), under exclusive licence to Cancer Research UK 2020 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-020-01186-9 ;PMID: 33262518

Full text available

12
Ipilimumab plus nivolumab and chemoradiotherapy followed by surgery in patients with resectable and borderline resectable T3-4N0-1 non-small cell lung cancer: the INCREASE trial
Material Type:
Article
Add to My Research

Ipilimumab plus nivolumab and chemoradiotherapy followed by surgery in patients with resectable and borderline resectable T3-4N0-1 non-small cell lung cancer: the INCREASE trial

BMC cancer, 2020-08, Vol.20 (1), p.764-10, Article 764 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-020-07263-9 ;PMID: 32795284

Full text available

13
Emerging therapeutic agents for advanced non-small cell lung cancer
Material Type:
Article
Add to My Research

Emerging therapeutic agents for advanced non-small cell lung cancer

Journal of hematology and oncology, 2020-05, Vol.13 (1), p.58-58, Article 58 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1756-8722 ;EISSN: 1756-8722 ;DOI: 10.1186/s13045-020-00881-7 ;PMID: 32448366

Full text available

14
miRNA-148a serves as a prognostic factor and suppresses migration and invasion through Wnt1 in non-small cell lung cancer
Material Type:
Article
Add to My Research

miRNA-148a serves as a prognostic factor and suppresses migration and invasion through Wnt1 in non-small cell lung cancer

PloS one, 2017-02, Vol.12 (2), p.e0171751-e0171751 [Peer Reviewed Journal]

COPYRIGHT 2017 Public Library of Science ;COPYRIGHT 2017 Public Library of Science ;2017 Chen et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2017 Chen et al 2017 Chen et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0171751 ;PMID: 28199399

Full text available

15
Circular RNA circ-CPA4/ let-7 miRNA/PD-L1 axis regulates cell growth, stemness, drug resistance and immune evasion in non-small cell lung cancer (NSCLC)
Material Type:
Article
Add to My Research

Circular RNA circ-CPA4/ let-7 miRNA/PD-L1 axis regulates cell growth, stemness, drug resistance and immune evasion in non-small cell lung cancer (NSCLC)

Journal of experimental & clinical cancer research, 2020-08, Vol.39 (1), p.149-149, Article 149 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1756-9966 ;ISSN: 0392-9078 ;EISSN: 1756-9966 ;DOI: 10.1186/s13046-020-01648-1 ;PMID: 32746878

Full text available

16
Deep learning for lung cancer prognostication: A retrospective multi-cohort radiomics study
Material Type:
Article
Add to My Research

Deep learning for lung cancer prognostication: A retrospective multi-cohort radiomics study

PLoS medicine, 2018-11, Vol.15 (11), p.e1002711 [Peer Reviewed Journal]

COPYRIGHT 2018 Public Library of Science ;COPYRIGHT 2018 Public Library of Science ;2018 Hosny et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2018 Hosny et al 2018 Hosny et al ;ISSN: 1549-1676 ;ISSN: 1549-1277 ;EISSN: 1549-1676 ;DOI: 10.1371/journal.pmed.1002711 ;PMID: 30500819

Full text available

17
Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer
Material Type:
Article
Add to My Research

Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer

PloS one, 2011-06, Vol.6 (6), p.e20351 [Peer Reviewed Journal]

COPYRIGHT 2011 Public Library of Science ;COPYRIGHT 2011 Public Library of Science ;2011 Dutt et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Dutt et al. 2011 ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0020351 ;PMID: 21666749

Full text available

18
Immune Cell Composition in Human Non-small Cell Lung Cancer
Material Type:
Article
Add to My Research

Immune Cell Composition in Human Non-small Cell Lung Cancer

Frontiers in immunology, 2019-02, Vol.9, p.3101 [Peer Reviewed Journal]

info:eu-repo/semantics/openAccess ;Copyright © 2019 Stankovic, Bjørhovde, Skarshaug, Aamodt, Frafjord, Müller, Hammarström, Beraki, Bækkevold, Woldbæk, Helland, Brustugun, Øynebråten and Corthay. 2019 Stankovic, Bjørhovde, Skarshaug, Aamodt, Frafjord, Müller, Hammarström, Beraki, Bækkevold, Woldbæk, Helland, Brustugun, Øynebråten and Corthay ;ISSN: 1664-3224 ;EISSN: 1664-3224 ;DOI: 10.3389/fimmu.2018.03101 ;PMID: 30774636

Full text available

19
Impact of interstitial lung disease and simultaneous lung cancer on therapeutic possibilities and survival
Material Type:
Article
Add to My Research

Impact of interstitial lung disease and simultaneous lung cancer on therapeutic possibilities and survival

Thoracic cancer, 2020-07, Vol.11 (7), p.1911-1917 [Peer Reviewed Journal]

2020 The Authors. published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd ;2020 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd. ;COPYRIGHT 2020 John Wiley & Sons, Inc. ;2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1759-7706 ;EISSN: 1759-7714 ;DOI: 10.1111/1759-7714.13481 ;PMID: 32401433

Full text available

20
Distribution of M1 and M2 macrophages in tumor islets and stroma in relation to prognosis of non-small cell lung cancer
Material Type:
Article
Add to My Research

Distribution of M1 and M2 macrophages in tumor islets and stroma in relation to prognosis of non-small cell lung cancer

BMC immunology, 2018-01, Vol.19 (1), p.3-3, Article 3 [Peer Reviewed Journal]

COPYRIGHT 2018 BioMed Central Ltd. ;COPYRIGHT 2018 BioMed Central Ltd. ;2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2018 ;ISSN: 1471-2172 ;EISSN: 1471-2172 ;DOI: 10.1186/s12865-018-0241-4 ;PMID: 29361917

Full text available

Results 1 - 20 of 218,374  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (200,430)

Refine My Results

Creation Date 

From To
  1. Before 1960  (5,851)
  2. 1960 To 1975  (4,674)
  3. 1976 To 1991  (9,222)
  4. 1992 To 2008  (25,851)
  5. After 2008  (172,786)
  6. More options open sub menu

Subject 

  1. Science & Technology  (175,583)
  2. Life Sciences & Biomedicine  (154,768)
  3. Humans  (103,836)
  4. Lung Cancer  (62,737)
  5. Male  (52,954)
  6. Female  (50,923)
  7. Animals  (41,415)
  8. Oncology  (37,600)
  9. Lungs  (36,611)
  10. Lung Diseases  (33,571)
  11. Middle Aged  (32,376)
  12. Patients  (32,034)
  13. Respiratory System  (31,522)
  14. Aged  (26,395)
  15. General & Internal Medicine  (25,774)
  16. Tumors  (25,259)
  17. Adult  (23,765)
  18. Mice  (23,376)
  19. Health Aspects  (23,354)
  20. Cancer  (22,766)
  21. More options open sub menu

Language 

  1. English  (213,122)
  2. Japanese  (23,558)
  3. Chinese  (3,728)
  4. Portuguese  (1,758)
  5. Korean  (1,112)
  6. Turkish  (354)
  7. French  (349)
  8. Spanish  (180)
  9. Norwegian  (90)
  10. Italian  (57)
  11. Polish  (50)
  12. German  (28)
  13. Russian  (16)
  14. Croatian  (15)
  15. Slovenian  (3)
  16. Lithuanian  (3)
  17. Afrikaans  (2)
  18. More options open sub menu

Searching Remote Databases, Please Wait